Table 12 List of the repositioning candidates, therapeutic category and the supporting published evidence in \(\#Cluster_5\)
From: Using informative features in machine learning based method for COVID-19 drug repurposing
Candidate drug | Therapeutic category | References |
|---|---|---|
Colchicine | Immunosuppressive agents | [26] |
Darunavir | Anti-infective agents | [26] |
Dexamethasone | Anti-inflammatory agents | [26] |
Methylprednisolone | Anti-inflammatory agents | [26] |
Tocilizumab | Antirheumatic agents | [26] |
Acetaminophen | Central nervous system agents | - |
Chloroquine | Anti-inflammatory agents | [26] |
Donepezil | Central nervous system agents | [70] |
Clomipramine | Central nervous system agents | [71] |
Resveratrol | Anti-inflammatory agents | [72] |
Curcumin | Anti-inflammatory agents | [73] |
Curcumin sulfate | anti-inflammatory agent | [74] |
Baricitinib | Antineoplastic and immunomodulating agents | [37] |
Lidocaine | Antiarrhythmic agents | [75] |